1080030P
The Vice President, Global Program Head (GPH) is an enterprise-level executive responsible for the end-to-end strategy, leadership, and delivery of a full portfolio within an assigned disease area, spanning multiple global programs from early development through regulatory approval and lifecycle management. This role integrates scientific, clinical, regulatory, and commercial strategy to shape a differentiated portfolio, maximize asset value, and ensure successful progression throughout the product life cycle. The GPH leads multiple complex matrix global program teams, anticipates future therapeutic and regulatory shifts, and ensures alignment across the full research–development–commercial spectrum.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 1080030P.
1080030P didn’t post a salary, so this is our estimate from similar listings.
Cell Therapy Strategy and Commercial Executive Director
AstraZeneca
Regulatory Program Management - Sponsor Dedicated
IQVIA
Senior Principal Scientist, Clinical Operations - Immunology
Merck & Co., Inc.
Director, RA Global Regulatory Strategy
AbbVie
VP, Global Program Lead - Cell Therapy
Bristol Myers Squibb
Director, RA Global Regulatory Strategy
AbbVie